Take a look at how OF2i® and our other BRAVE innovations are in use in pharmaceutical applications.
The particle size distribution of parenteral emulsions is a critical quality attribute (CQA).
The BRAVE process sensor continuously monitors the PSD distribution and automatically evaluates data such as D-values to assess the efficiency of the homogenization steps involved in producing these emulsions.
from water analysis to research into soil composition and investigating pollutants
parenteral nutrition, painkillers, water for injections, therapeutic protein injectibles
understanding and optimizing protein-protein interactions, lipoproteins, VLPs, EVs, cell cultures
from suncreen to shampoo, skin creams to mouth wash
quality monitoring in the wet production of semiconductors
curiosity takes our partners to many places and results in wonderful discoveries
BRAVE ANALYTICS
Our expertise
As a partner in the MOZART project (MOZART for safe & sustainable by-design metallic coatings & engineered surfaces (RIA)), we received funding from the European Commission as part of the EU Horizon 2020 program.